Credit Suisse’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,802
| Closed | -$276K | – | 3154 |
|
|
2023
Q1 | $276K | Buy |
3,802
+339
| +10% | +$24.6K | ﹤0.01% | 3008 |
|
|
2022
Q4 | $284K | Buy |
3,463
+1,002
| +41% | +$82.2K | ﹤0.01% | 3053 |
|
|
2022
Q3 | $232K | Buy |
2,461
+44
| +2% | +$4.15K | ﹤0.01% | 3169 |
|
|
2022
Q2 | $471K | Sell |
2,417
-175
| -7% | -$34.1K | ﹤0.01% | 2861 |
|
|
2022
Q1 | $602K | Buy |
2,592
+188
| +8% | +$43.7K | ﹤0.01% | 2847 |
|
|
2021
Q4 | $946K | Sell |
2,404
-32,026
| -93% | -$12.6M | ﹤0.01% | 2624 |
|
|
2021
Q3 | $15.4M | Sell |
34,430
-14,802
| -30% | -$6.62M | 0.01% | 917 |
|
|
2021
Q2 | $19.1M | Sell |
49,232
-51,076
| -51% | -$19.9M | 0.01% | 844 |
|
|
2021
Q1 | $36M | Buy |
100,308
+47,128
| +89% | +$16.9M | 0.02% | 637 |
|
|
2020
Q4 | $26.1M | Sell |
53,180
-1,324
| -2% | -$650K | 0.01% | 729 |
|
|
2020
Q3 | $17.7M | Sell |
54,504
-8,555
| -14% | -$2.77M | 0.01% | 788 |
|
|
2020
Q2 | $23M | Buy |
63,059
+61,155
| +3,212% | +$22.3M | 0.02% | 679 |
|
|
2020
Q1 | $405K | Sell |
1,904
-438
| -19% | -$93.2K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $964K | Buy |
2,342
+1,032
| +79% | +$425K | ﹤0.01% | 2537 |
|
|
2019
Q3 | $462K | Buy |
1,310
+302
| +30% | +$107K | ﹤0.01% | 2842 |
|
|
2019
Q2 | $507K | Sell |
1,008
-20
| -2% | -$10.1K | ﹤0.01% | 2774 |
|
|
2019
Q1 | $1.02M | Sell |
1,028
-59
| -5% | -$58.7K | ﹤0.01% | 2353 |
|
|
2018
Q4 | $944K | Buy |
1,087
+172
| +19% | +$149K | ﹤0.01% | 2328 |
|
|
2018
Q3 | $946K | Sell |
915
-589
| -39% | -$609K | ﹤0.01% | 2463 |
|
|
2018
Q2 | $1.38M | Sell |
1,504
-130
| -8% | -$119K | ﹤0.01% | 2364 |
|
|
2018
Q1 | $1.59M | Buy |
1,634
+871
| +114% | +$849K | ﹤0.01% | 2230 |
|
|
2017
Q4 | $345K | Sell |
763
-260
| -25% | -$118K | ﹤0.01% | 3088 |
|
|
2017
Q3 | $423K | Buy |
1,023
+490
| +92% | +$203K | ﹤0.01% | 3109 |
|
|
2017
Q2 | $187K | Sell |
533
-617
| -54% | -$216K | ﹤0.01% | 3243 |
|
|
2017
Q1 | $591K | Sell |
1,150
-384
| -25% | -$197K | ﹤0.01% | 2825 |
|
|
2016
Q4 | $544K | Buy |
1,534
+697
| +83% | +$247K | ﹤0.01% | 3049 |
|
|
2016
Q3 | $447K | Buy |
837
+14
| +2% | +$7.48K | ﹤0.01% | 3144 |
|
|
2016
Q2 | $463K | Buy |
823
+287
| +54% | +$161K | ﹤0.01% | 3175 |
|
|
2016
Q1 | $255K | Sell |
536
-501
| -48% | -$238K | ﹤0.01% | 3286 |
|
|
2015
Q4 | $685K | Buy |
1,037
+626
| +152% | +$414K | ﹤0.01% | 2917 |
|
|
2015
Q3 | $323K | Buy |
411
+149
| +57% | +$117K | ﹤0.01% | 3467 |
|
|
2015
Q2 | $346K | Buy |
+262
| New | +$346K | ﹤0.01% | 3661 |
|